Search

  • HOME
  • Search
Original Article
1752
The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
George Chen, Bubu Banini, Albert Do, Joseph K. Lim
Clin Mol Hepatol. 2023;29(Suppl):S319-S332.   Published online December 14, 2022
View: 722   Download: 55
Review
1726
Non-alcoholic fatty liver disease: the pathologist’s perspective
Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
Clin Mol Hepatol. 2023;29(Suppl):S302-S318.   Published online November 15, 2022
View: 1204   Download: 152
1759
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
Clin Mol Hepatol. 2023;29(Suppl):S286-S301.   Published online December 28, 2022
View: 1141   Download: 114
Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
Jihyun An, Joo Hyun Sohn
Clin Mol Hepatol. 2023;29(Suppl):S268-S275.   Published online December 20, 2022
View: 748   Download: 108
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
Hyunwoo Oh, Won Sohn, Yong Kyun Cho
Clin Mol Hepatol. 2023;29(Suppl):S261-S267.   Published online December 22, 2022
View: 614   Download: 47
1721
Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol. 2023;29(Suppl):S220-S227.   Published online November 10, 2022
View: 922   Download: 79
1710
Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Karim Seif El Dahan, Darine Daher, Amit G. Singal
Clin Mol Hepatol. 2023;29(Suppl):S207-S219.   Published online September 14, 2022
View: 3833   Download: 94  Citation: 1
1741
Identification of high-risk subjects in nonalcoholic fatty liver disease
Christiane Stern, Laurent Castera
Clin Mol Hepatol. 2023;29(Suppl):S196-S206.   Published online December 5, 2022
View: 1979   Download: 208
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Terry Cheuk-Fung Yip, Fei Lyu, Huapeng Lin, Guanlin Li, Pong-Chi Yuen, Vincent Wai-Sun Wong, Grace Lai-Hung Wong
Clin Mol Hepatol. 2023;29(Suppl):S171-S183.   Published online December 12, 2022
View: 1080   Download: 155  Citation: 1
1728
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
Clin Mol Hepatol. 2023;29(Suppl):S157-S170.   Published online November 22, 2022
View: 1029   Download: 188
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Sang Bong Ahn
Clin Mol Hepatol. 2023;29(Suppl):S150-S156.   Published online January 25, 2023
View: 612   Download: 93
1744
Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
Jung Hwan Yu, Han Ah Lee, Seung Up Kim
Clin Mol Hepatol. 2023;29(Suppl):S136-S149.   Published online December 12, 2022
View: 802   Download: 104
1742
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Asako Nogami, Masato Yoneda, Michihiro Iwaki, Takashi Kobayashi, Yasushi Honda, Yuji Ogawa, Kento Imajo, Satoru Saito, Atsushi Nakajima
Clin Mol Hepatol. 2023;29(Suppl):S123-S135.   Published online December 12, 2022
View: 842   Download: 112
1737
Screening strategy for non-alcoholic fatty liver disease
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Clin Mol Hepatol. 2023;29(Suppl):S103-S122.   Published online November 30, 2022
View: 1179   Download: 117
1762
Nonalcoholic fatty liver disease and non-liver comorbidities
Richie Manikat, Mindie H. Nguyen
Clin Mol Hepatol. 2023;29(Suppl):s86-s102.   Published online January 5, 2023
View: 710   Download: 75
Risk factors in nonalcoholic fatty liver disease
Eunji Ko, Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2023;29(Suppl):S79-S85.   Published online December 14, 2022
View: 1110   Download: 119  Citation: 1
1739
Comparison between obese and non-obese nonalcoholic fatty liver disease
Wah-Kheong Chan
Clin Mol Hepatol. 2023;29(Suppl):S58-S67.   Published online December 5, 2022
View: 852   Download: 104
1729
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clin Mol Hepatol. 2023;29(Suppl):S43-S57.   Published online November 22, 2022
View: 972   Download: 87
1748
Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
Clin Mol Hepatol. 2023;29(Suppl):S32-S42.   Published online December 14, 2022
View: 1009   Download: 121  Citation: 1
Non-alcoholic fatty liver disease: Definition and subtypes
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Clin Mol Hepatol. 2023;29(suppl):S5-S16.   Published online December 28, 2022
View: 1135   Download: 195
Snapshot
1750
Epidemiology and updated management for autoimmune liver disease
Nae-Yun Heo, Haeryoung Kim
Clin Mol Hepatol. 2023;29(1):194-196.   Published online December 14, 2022
View: 1086   Download: 85
Correspondence
Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani
Clin Mol Hepatol. 2023;29(1):188-190.   Published online November 22, 2022
View: 1038   Download: 40
Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clin Mol Hepatol. 2023;29(1):185-187.   Published online November 10, 2022
View: 809   Download: 22
Letter to the Editor
Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
Clin Mol Hepatol. 2023;29(1):176-178.   Published online November 10, 2022
View: 877   Download: 37
Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
Clin Mol Hepatol. 2023;29(1):173-175.   Published online November 15, 2022
View: 817   Download: 26
Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clin Mol Hepatol. 2023;29(1):168.   Published online October 31, 2022
View: 1076   Download: 40  Citation: 1
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 813
TOTAL : 1224323
Close layer